HealthTab Enters Multi-Year Collaboration with Abbott for UK Point-of-Care Testing

M&A · Partnership
โดย GlobeNewswire·GBUS·Read original
Summary · why it matters

Avricore Health's subsidiary HealthTab has signed a multi-year collaboration agreement with Abbott to supply and distribute Abbott's point-of-care testing products through the HealthTab platform in the UK. The agreement allows HealthTab to distribute Abbott's Afinion 2 Analyzer in NHS-linked pharmacies to test for HbA1c and lipid profiles, and establishes a framework for expanding point-of-care testing through community pharmacies. CEO Rodger Seccombe called it the company's most significant milestone to date, citing fifteen years of building the pharmacy-based testing model and the need for an industry-leading partner. HealthTab provides a turnkey solution including instruments, consumables, onboarding, training, and a secure cloud-based platform connecting analyzers, patient results, QC data, and pharmacist workflows. The platform's quality program, run with reference laboratory CEQAL, includes centralized lot monitoring, internal quality control, and external quality-assessment events to ensure accurate and traceable results.

Impact on stocks 1

Biotech & Genomic Medicine▲ · 1 stocks
Abbott Laboratories
ABT
▲ PositiveDemandrelevance

Abbott's point-of-care products gain distribution through HealthTab's UK pharmacy network.

Off-coverage companies 2

Avricore Health Inc.Private▲ Positive
Demandrelevance

HealthTab signs multi-year collaboration with Abbott to distribute products in UK, expanding its platform.

HealthTabPrivate▲ Positive
Demandrelevance

HealthTab platform will supply and distribute Abbott's Afinion 2 Analyzer in NHS-linked pharmacies.

© 2026 MarketDXNews